News

InterShunt has initiated the EASE HF2 early feasibility study of the InterShunt percutaneous atrial shunt catheter (PAS-C) ...
Philips has announced the expansion of its collaboration with Medtronic, focusing on advancing patient monitoring ...
It is no secret that the UK’s National Health Service (NHS), like many other healthcare systems, is under pressure on ...
Spiders can be an uncomfortable presence for many people but thanks to a new development, their silk is set to enhance nerve ...
Enterra Medical has commenced the randomised, multi-centre NAVIGATE study, designed to assess Gastric Electrical Stimulation ...
Nanostics has secured funding from Genome Canada and Genome Alberta to expedite the ClarityDX Prostate test integration into ...
Glaukos has secured EU Medical Device Regulation (EU-MDR) certification for its iStent infinite, along with other MIGS ...
Medical Research Council (MRC) has launched a new £50m ($68.6m) centre spread across collaborator sites in the UK to develop ...
The FDA label update boosts GE HealthCare’s Vizamyl to a market advantage despite the emergence of blood-based tests.
A professor from the University of Sheffield has received over £0.39m ($0.45m) in funding from Breast Cancer Now to develop a ...
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Stryker’s Incompass Total Ankle System.
Drug discovery has traditionally been slow, expensive and prone to failure, but AI and machine learning are set to change all ...